biopharmaapac.com Open in urlscan Pro
2a02:4780:39:8769:4c98:84fc:e60:ca1  Public Scan

Submitted URL: https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwia...
Effective URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y...
Submission Tags: falconsandbox
Submission: On May 17 via api from US — Scanned from DE

Summary

This website contacted 9 IPs in 4 countries across 8 domains to perform 41 HTTP transactions. The main IP is 2a02:4780:39:8769:4c98:84fc:e60:ca1, located in Singapore, Singapore and belongs to AS-HOSTINGER, CY. The main domain is biopharmaapac.com.
TLS certificate: Issued by R3 on May 6th 2024. Valid for: 3 months.
This is the only time biopharmaapac.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

Apex Domain
Subdomains
Transfer
28 biopharmaapac.com
biopharmaapac.com
715 KB
5 google.com
www.google.com — Cisco Umbrella Rank: 2
946 B
2 twitter.com
platform.twitter.com — Cisco Umbrella Rank: 1357
28 KB
1 google-analytics.com
region1.google-analytics.com — Cisco Umbrella Rank: 2533
255 B
1 gstatic.com
www.gstatic.com
207 KB
1 googletagmanager.com
www.googletagmanager.com — Cisco Umbrella Rank: 39
99 KB
1 youtube.com
www.youtube.com — Cisco Umbrella Rank: 64
1 dripemail2.com
t.dripemail2.com — Cisco Umbrella Rank: 191453
261 B
41 8
Domain Requested by
28 biopharmaapac.com biopharmaapac.com
5 www.google.com biopharmaapac.com
www.gstatic.com
2 platform.twitter.com biopharmaapac.com
platform.twitter.com
1 region1.google-analytics.com www.googletagmanager.com
1 www.gstatic.com www.google.com
1 www.googletagmanager.com biopharmaapac.com
1 www.youtube.com biopharmaapac.com
1 t.dripemail2.com 1 redirects
41 8
Subject Issuer Validity Valid
biopharmaapac.com
R3
2024-05-06 -
2024-08-04
3 months crt.sh
*.google.com
WR2
2024-05-06 -
2024-07-29
3 months crt.sh
*.twimg.com
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2023-07-28 -
2024-07-26
a year crt.sh
*.google-analytics.com
WR2
2024-05-06 -
2024-07-29
3 months crt.sh
*.gstatic.com
WR2
2024-05-06 -
2024-07-29
3 months crt.sh

This page contains 7 frames:

Primary Page: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Frame ID: 5388E8F60A6A06BFF3836EC2685C8D0B
Requests: 35 HTTP requests in this frame

Frame: https://www.youtube.com/embed/lOcQEjAN7YU
Frame ID: C233F964C2E85285B2AF2A2F581BB896
Requests: 1 HTTP requests in this frame

Frame: https://platform.twitter.com/widgets/widget_iframe.2f70fb173b9000da126c79afe2098f02.html?origin=https%3A%2F%2Fbiopharmaapac.com
Frame ID: F837652488625B1C352485DDCAA491BF
Requests: 1 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=8k85QBI-qzxmenDv318AZH30&size=normal&cb=yzdymkvhn15o
Frame ID: 30078ED117721020CD560D1B0660D3E8
Requests: 1 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=8k85QBI-qzxmenDv318AZH30&size=normal&cb=3hclid9yean6
Frame ID: 580C23838B5A35D7F2979FBA282B868B
Requests: 1 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/bframe?hl=de&v=8k85QBI-qzxmenDv318AZH30&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC
Frame ID: DB180C691DEE3CAF2F24250F3D689561
Requests: 1 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/bframe?hl=de&v=8k85QBI-qzxmenDv318AZH30&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC
Frame ID: 1FC5ACB134C0F2DB14F7E19D3D2927CB
Requests: 1 HTTP requests in this frame

Screenshot

Page Title

Oscotec/ADEL Receives FDA Clearance for Alzheimer's Treatment IND Application (ADEL-Y01)

Page URL History Show full URLs

  1. https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6I... HTTP 307
    https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-in... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • <link[^>]* href=[^>]*?bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.css
  • bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.js

Overall confidence: 100%
Detected patterns
  • <link[^>]* href=[^>]+(?:([\d.]+)/)?(?:css/)?font-awesome(?:\.min)?\.css
  • <link[^>]* href=[^>]*?(?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)
  • (?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:.*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)

Overall confidence: 100%
Detected patterns

Overall confidence: 100%
Detected patterns
  • googletagmanager\.com/gtag/js

Overall confidence: 100%
Detected patterns
  • //platform\.twitter\.com/widgets\.js

Overall confidence: 100%
Detected patterns
  • jquery[.-]([\d.]*\d)[^/]*\.js
  • jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

Overall confidence: 100%
Detected patterns
  • /recaptcha/api\.js

Page Statistics

41
Requests

95 %
HTTPS

67 %
IPv6

8
Domains

8
Subdomains

9
IPs

4
Countries

1050 kB
Transfer

1959 kB
Size

6
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.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.69mCMc26O24Y1Wc56TUyJ7W4vCOQmFHHpcsOFZuFz50 HTTP 307
    https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

41 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html
biopharmaapac.com/news/83/3647/
Redirect Chain
  • https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwiaWF0IjoxNjk0NzQ1NDM3LCJuYmYiOjE2OTQ3NDU0MzcsImFjY291bnRfaWQiOiI2MTU3NjEzIiwiZ...
  • https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campa...
54 KB
16 KB
Document
General
Full URL
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:39:8769:4c98:84fc:e60:ca1 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn / PHP/7.0.33
Resource Hash
5d2b1124fcdbb7493f54f2e426f2dc2b6c1b3716d7502f881aadf7a9bcb68e75
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

Accept-Language
de-DE,de;q=0.9;q=0.9
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=86400
cache-control
no-cache
content-encoding
br
content-security-policy
upgrade-insecure-requests
content-type
text/html; charset=UTF-8
date
Fri, 17 May 2024 17:05:46 GMT
platform
hostinger
server
hcdn
x-hcdn-cache-status
DYNAMIC
x-hcdn-request-id
312038a043a8cd6a2f3af37103bcea03-nme-edge4
x-hcdn-upstream-rt
1.281
x-powered-by
PHP/7.0.33

Redirect headers

content-length
0
date
Fri, 17 May 2024 17:05:44 GMT
location
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
bootstrap.min.css
biopharmaapac.com/bundles/taai/app/site/css/
157 KB
21 KB
Stylesheet
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/css/bootstrap.min.css
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:39:8769:4c98:84fc:e60:ca1 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
f77c0d1739b618edc4a01ca3f6b2990b01a3009030af49ee8cf68e83052df194
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:47 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
4
alt-svc
h3=":443"; ma=86400
content-length
21008
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"27288-658841b5-c558fc44806ec9b6;br"
x-hcdn-request-id
50b88f7ebc6d238b901d10c7eaf816cf-nme-edge4
content-type
text/css
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 17:05:43 GMT
style.css
biopharmaapac.com/bundles/taai/app/site/css/
25 KB
6 KB
Stylesheet
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:39:8769:4c98:84fc:e60:ca1 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
ebdc5cfff9a360616e819fbd3cb79de32c18c8cc9bf5fde761c69b015ccab1d5
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:47 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
4
alt-svc
h3=":443"; ma=86400
content-length
5242
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"6585-658841b5-d7545e5fc4eb3b36;br"
x-hcdn-request-id
a7aecc193cd2a40bf0ede9d0989c9f56-nme-edge4
content-type
text/css
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 17:05:43 GMT
font-awesome.min.css
biopharmaapac.com/bundles/taai/app/site/css/
20 KB
5 KB
Stylesheet
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/css/font-awesome.min.css
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:39:8769:4c98:84fc:e60:ca1 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
b769324e0921f9f649611113e65f528ebae5e140da8a7e63c5d6ea7bc7a33bc0
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:47 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
4
alt-svc
h3=":443"; ma=86400
content-length
4377
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"511e-658841b5-37cf0363bbbb9110;br"
x-hcdn-request-id
a538350edf2a69aeec631e15eff2ce2f-nme-edge4
content-type
text/css
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 17:05:43 GMT
normalize.min.css
biopharmaapac.com/bundles/taai/app/site/css/
2 KB
1 KB
Stylesheet
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/css/normalize.min.css
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:39:8769:4c98:84fc:e60:ca1 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
b76ffbb2665f82b493e054b50d3d1bb3f2a8b4233be1795ca9937956eef196bc
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:47 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
4
alt-svc
h3=":443"; ma=86400
content-length
807
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"897-658841b5-7766ac21e4fe004a;br"
x-hcdn-request-id
e01d33bec1b576310c9326bb650d5582-nme-edge4
content-type
text/css
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 17:05:43 GMT
custom-style.css
biopharmaapac.com/bundles/taai/app/site/css/
342 B
543 B
Stylesheet
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/css/custom-style.css
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:39:8769:4c98:84fc:e60:ca1 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
e65117229d77c2ee86fca1f8753df08d81434bf55569e574a03bcabce77ce436
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:47 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
4
alt-svc
h3=":443"; ma=86400
content-length
153
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"156-658841b5-b5014e6d05cc6cea;br"
x-hcdn-request-id
d8fd7e8e51dc1b1380ba444a95da37c5-nme-edge4
content-type
text/css
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 17:05:43 GMT
logo.jpg
biopharmaapac.com/bundles/taai/app/site/images/
5 KB
6 KB
Image
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/images/logo.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:39:8769:4c98:84fc:e60:ca1 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
2d4d0901e283ba28355eeb5a5e942a66ea4659922635c24fbea0244ed1598dc5

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:47 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
2
x-hcdn-request-id
58dc38ff672e94c585e651ab4057ad00-nme-edge4
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
5460
displayad_bioflo320_728x90px_en-58.gif
biopharmaapac.com/uploads/static/
67 KB
67 KB
Image
General
Full URL
https://biopharmaapac.com/uploads/static/displayad_bioflo320_728x90px_en-58.gif
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:39:8769:4c98:84fc:e60:ca1 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
727716580a27f67355a553de8a1ee6c1b0b96e3d31e403c26a50a8d0e38fc57a
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:47 GMT
content-security-policy
upgrade-insecure-requests
age
4
alt-svc
h3=":443"; ma=86400
content-length
68096
x-hcdn-cache-status
HIT
last-modified
Tue, 30 Apr 2024 07:41:18 GMT
server
hcdn
etag
"10a00-6630a09e-f7360aa79256a458;;;"
x-hcdn-request-id
c334dd4fb818e8e81bc4e247568c06ab-nme-edge4
content-type
image/gif
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 17:05:43 GMT
17247404334195733326-59.jpg
biopharmaapac.com/uploads/static/
15 KB
15 KB
Image
General
Full URL
https://biopharmaapac.com/uploads/static/17247404334195733326-59.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:39:8769:4c98:84fc:e60:ca1 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
59f4391fc8620567a220740e662586c344e814b6a10a6e89b8f301774d6ee338

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:47 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
3
x-hcdn-request-id
7ada06a6acfc3c4fc9b6f2608d1f159b-nme-edge4
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
15390
alzheimers_c-3647.jpg
biopharmaapac.com/uploads/articles/
102 KB
102 KB
Image
General
Full URL
https://biopharmaapac.com/uploads/articles/alzheimers_c-3647.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:39:8769:4c98:84fc:e60:ca1 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
c76892a0dced9f2912704a04b724f72d93ba83e61681da7c2fd1f753755fb159

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:50 GMT
x-hcdn-cache-status
MISS
server
hcdn
x-hcdn-request-id
8f8a8cd1aa287188af00ce9b3f469290-nme-edge4
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
x-hcdn-upstream-rt
3.182
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
104040
16421605736357482910-2105.png
biopharmaapac.com/uploads/static/
24 KB
24 KB
Image
General
Full URL
https://biopharmaapac.com/uploads/static/16421605736357482910-2105.png
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:39:8769:4c98:84fc:e60:ca1 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
a94ec9082fdaf7a1274e6159c1aada2f7dad7adf2bbddd7033812740af162153

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:49 GMT
x-hcdn-cache-status
MISS
server
hcdn
x-hcdn-request-id
1fc87a1e4bb9d316767c412c1e88f0f5-nme-edge4
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
x-hcdn-upstream-rt
1.620
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
24572
biotitan_banner_300x250_v_2-61.jpg
biopharmaapac.com/uploads/static/
11 KB
11 KB
Image
General
Full URL
https://biopharmaapac.com/uploads/static/biotitan_banner_300x250_v_2-61.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:39:8769:4c98:84fc:e60:ca1 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
e2f10adc52e292836413e9bb155a379f5cf0ddbd78044a24d645a85b866bdc76

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:47 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
1
x-hcdn-request-id
70a744ede2e0aabf4dbb4e7e52718571-nme-edge4
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
11504
biopharma_apac_website_banner_300_x_150_px_2_-64.png
biopharmaapac.com/uploads/static/
11 KB
11 KB
Image
General
Full URL
https://biopharmaapac.com/uploads/static/biopharma_apac_website_banner_300_x_150_px_2_-64.png
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:39:8769:4c98:84fc:e60:ca1 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
2ea8b83f155a1c7a1b24ef264a3cdc3e0ccf8627d447962adc7168225855b10c

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:47 GMT
x-hcdn-cache-status
HIT
server
hcdn
age
2
x-hcdn-request-id
26a23c3e8e0123f2fe6d2cf24668d2a7-nme-edge4
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
11080
unnamed-62.gif
biopharmaapac.com/uploads/static/
36 KB
37 KB
Image
General
Full URL
https://biopharmaapac.com/uploads/static/unnamed-62.gif
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:39:8769:4c98:84fc:e60:ca1 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
461c3cb2d353f837be8a4d1b9ed67e8accdce9af1d69fb0819e9c3d593fb06e0
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:47 GMT
content-security-policy
upgrade-insecure-requests
age
3
alt-svc
h3=":443"; ma=86400
content-length
37253
x-hcdn-cache-status
HIT
last-modified
Thu, 15 Feb 2024 04:36:58 GMT
server
hcdn
etag
"9185-65cd94ea-254f3b0d30889995;;;"
x-hcdn-request-id
5367478448776b25e64c67df0fa6daf2-nme-edge4
content-type
image/gif
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 17:05:44 GMT
14280220722498395040-63.jpg
biopharmaapac.com/uploads/static/
10 KB
11 KB
Image
General
Full URL
https://biopharmaapac.com/uploads/static/14280220722498395040-63.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:39:8769:4c98:84fc:e60:ca1 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
564dc88c3ff6fcd82cfb3b2c3922829ee3540abd0566d80e12885ab8221baca8

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:49 GMT
x-hcdn-cache-status
MISS
server
hcdn
x-hcdn-request-id
1c1b74b047f7ede492a2df886e5835dd-nme-edge4
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
x-hcdn-upstream-rt
1.856
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
10666
lOcQEjAN7YU
www.youtube.com/embed/ Frame C233
0
0
Document
General
Full URL
https://www.youtube.com/embed/lOcQEjAN7YU
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9;q=0.9
Referer
https://biopharmaapac.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
br
content-type
text/html; charset=utf-8
cross-origin-opener-policy-report-only
same-origin; report-to="youtube_main"
cross-origin-resource-policy
cross-origin
date
Fri, 17 May 2024 17:05:47 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
origin-trial
AmhMBR6zCLzDDxpW+HfpP67BqwIknWnyMOXOQGfzYswFmJe+fgaI6XZgAzcxOrzNtP7hEDsOo1jdjFnVr2IdxQ4AAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTc1ODA2NzE5OSwiaXNTdWJkb21haW4iOnRydWV9
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=de for more info."
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
pragma
no-cache
report-to
{"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
server
ESF
strict-transport-security
max-age=31536000
vary
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
x-content-type-options
nosniff
x-xss-protection
0
biopharma_apac_women_s_day_special-4471.jpg
biopharmaapac.com/uploads/articles/
0
0

screenshot_2023_12_13_at_9_44_52_am_1_-4048.jpg
biopharmaapac.com/uploads/articles/
0
0

screenshot_2023_12_12_at_9_45_03_pm-4050.jpg
biopharmaapac.com/uploads/articles/
69 KB
70 KB
Image
General
Full URL
https://biopharmaapac.com/uploads/articles/screenshot_2023_12_12_at_9_45_03_pm-4050.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:39:8769:4c98:84fc:e60:ca1 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
fb58550a82dc1147bd4dd6896f9b37a844ad655377c361757eb9f64c9e732235

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:50 GMT
x-hcdn-cache-status
MISS
server
hcdn
x-hcdn-request-id
21d086a40159cd3fdf4748eef3a613d1-nme-edge4
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
x-hcdn-upstream-rt
2.740
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
70900
BPA-Newsletter.jpg
biopharmaapac.com/bundles/taai/app/site/images/
16 KB
17 KB
Image
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/images/BPA-Newsletter.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:4780:39:8769:4c98:84fc:e60:ca1 Singapore, Singapore, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
bef28bfc8c1557bc5c4e5ebab4bddbdb6bd154d3b3d3c46b6d5294fc96b1c7cf

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:49 GMT
x-hcdn-cache-status
MISS
server
hcdn
x-hcdn-request-id
8c06b1edbdf243f3e1633f7361d09b3d-nme-edge4
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
x-hcdn-upstream-rt
2.358
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
16702
jquery-3.6.0.min.js
biopharmaapac.com/bundles/taai/app/site/js/
87 KB
30 KB
Script
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/js/jquery-3.6.0.min.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
154.62.105.146 Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
ff1523fb7389539c84c65aba19260648793bb4f5e29329d2ee8804bc37a3fe6e
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:47 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
alt-svc
h3=":443"; ma=86400
content-length
30021
x-hcdn-cache-status
MISS
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"15d9d-658841b5-76abcfcbc9734b31;br"
x-hcdn-request-id
8148faca0c3ffe48a09b6e0cb8b0a206-srv-edge5
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
x-hcdn-upstream-rt
0.422
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 17:05:47 GMT
popper.min.js
biopharmaapac.com/bundles/taai/app/site/js/
21 KB
7 KB
Script
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/js/popper.min.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
154.62.105.146 Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
c776195ad46333c6c9a9fe3c74502ffea9a02faf122388ea3567922cc65a3060
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:47 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
0
alt-svc
h3=":443"; ma=86400
content-length
7193
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"5309-658841b5-f0a1cf827833c88e;br"
x-hcdn-request-id
f3029994651dfab8431ba9e2cb188503-srv-edge5
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 17:05:47 GMT
bootstrap.min.js
biopharmaapac.com/bundles/taai/app/site/js/
62 KB
14 KB
Script
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/js/bootstrap.min.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
154.62.105.146 Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
d8968086f7509df34c3278563dab87399da4f9dcdfb419818e3a309eedc70b88
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:47 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
alt-svc
h3=":443"; ma=86400
content-length
14080
x-hcdn-cache-status
MISS
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"f708-658841b5-af11bc98bc815e7d;br"
x-hcdn-request-id
7fabb3d1fb6e8e08ac442d131ec2b19d-srv-edge5
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
x-hcdn-upstream-rt
0.421
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 17:05:47 GMT
jquery.autoscroll.js
biopharmaapac.com/bundles/taai/app/site/js/
1 KB
954 B
Script
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/js/jquery.autoscroll.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
154.62.105.146 Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
c6be6411d784cb509362d794eb35273a24661f430ef0858982cac95fbb23e23d
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:47 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
0
alt-svc
h3=":443"; ma=86400
content-length
565
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"59b-658841b5-93f15deffd8af24b;br"
x-hcdn-request-id
65bec52f8587e1b5a5a99d3ec0c04961-srv-edge5
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 17:05:47 GMT
script.js
biopharmaapac.com/bundles/taai/app/site/js/
8 KB
2 KB
Script
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/js/script.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
154.62.105.146 Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
6ac1a1a6d852a4b597abee6351f122b5363f1c3f153df5a2b60336bbbe61069d
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:47 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
0
alt-svc
h3=":443"; ma=86400
content-length
1868
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"1ed5-658841b5-3be2fb36bd88fc41;br"
x-hcdn-request-id
f5d8f42e7564e286c12cb72b7f7dec5c-srv-edge5
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 17:05:47 GMT
dips-site-common.js
biopharmaapac.com/bundles/taai/app/site/js/
5 KB
2 KB
Script
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/js/dips-site-common.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
154.62.105.146 Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
b316099d3d0439715256c4bf9b8b59f2323a0af63e65b33e668a1eb3972f2893
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:47 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
0
alt-svc
h3=":443"; ma=86400
content-length
1639
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"13f4-658841b5-e31a95c6373499c0;br"
x-hcdn-request-id
885ab518e10ae082c430f34fd934a3ea-srv-edge5
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 17:05:47 GMT
api.js
www.google.com/recaptcha/
1 KB
946 B
Script
General
Full URL
https://www.google.com/recaptcha/api.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
216.58.212.132 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
ams15s21-in-f4.1e100.net
Software
GSE /
Resource Hash
6fc1c99f6d9a1a516f7be4a6a7242d988bcb73a9274e66eb9cc30772c2261c81
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self'
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:47 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy
frame-ancestors 'self'
server
GSE
x-frame-options
SAMEORIGIN
content-type
text/javascript; charset=utf-8
cache-control
private, max-age=300
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
1; mode=block
expires
Fri, 17 May 2024 17:05:47 GMT
widgets.js
platform.twitter.com/
91 KB
28 KB
Script
General
Full URL
https://platform.twitter.com/widgets.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2606:2800:234:59:254c:406:2366:268c , United States, ASN15133 (EDGECAST, US),
Reverse DNS
Software
ECS (frb/67D5) /
Resource Hash
173460e89e6a7244218badae2016f65c48a3eae9d400802273eeca18b07336f1

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

Date
Fri, 17 May 2024 17:05:47 GMT
Content-Encoding
gzip
Age
1005
x-amz-server-side-encryption
AES256
X-Cache
HIT
P3P
CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
Server-Timing
x-cache;desc= HIT,x-tw-cdn;desc=VZ
Content-Length
27597
Last-Modified
Mon, 11 Dec 2023 17:20:28 GMT
Server
ECS (frb/67D5)
Etag
"824beb891744db98ccbd3a456e59e0f7+gzip"
Access-Control-Max-Age
3000
Access-Control-Allow-Methods
GET
Content-Type
application/javascript; charset=utf-8
Access-Control-Allow-Origin
*
x-tw-cdn
VZ
Cache-Control
public, max-age=1800
Vary
Accept-Encoding
articulate.min.js
biopharmaapac.com/bundles/taai/assets/global/plugins/text-to-speech/
8 KB
3 KB
Script
General
Full URL
https://biopharmaapac.com/bundles/taai/assets/global/plugins/text-to-speech/articulate.min.js
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
154.62.105.146 Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
a8a2031f7cb98a60f55670a991ce71d4b61aaf051a4bf4eaccb2620b218516ec
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:47 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
age
0
alt-svc
h3=":443"; ma=86400
content-length
2410
x-hcdn-cache-status
HIT
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"1e7c-658841b5-526d778e2c41316a;br"
x-hcdn-request-id
0765d6b225fb412c69a268a04ae9af61-srv-edge5
content-type
application/x-javascript
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 17:05:47 GMT
js
www.googletagmanager.com/gtag/
293 KB
99 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-2E2BXNMKP4
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
0127722c4ced50e57ace03341e6bf77bca747afef5e5bdc9a4514702b234c9f2
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:47 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
access-control-allow-headers
Cache-Control
content-length
101459
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Fri, 17 May 2024 17:05:47 GMT
back-web.jpg
biopharmaapac.com/bundles/taai/app/site/images/
132 KB
133 KB
Image
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/images/back-web.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
154.62.105.146 Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
4a0238590c45138d7cb407a8270180fe598d45803283ebc70c21cf0661219e4c

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:48 GMT
x-hcdn-cache-status
MISS
server
hcdn
x-hcdn-request-id
1b0ddc127f23b70a7eee596f91476229-srv-edge5
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
x-hcdn-upstream-rt
1.089
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
135668
newsletter-back-Banner.jpg
biopharmaapac.com/bundles/taai/app/site/images/
22 KB
22 KB
Image
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/images/newsletter-back-Banner.jpg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
154.62.105.146 Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
1a55549577f4b44e7e810531834d5ec8648857b39832ab3567032fd1bfd4deaa

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:48 GMT
x-hcdn-cache-status
MISS
server
hcdn
x-hcdn-request-id
041734754cd6a8e07c765b8ed5eb66c7-srv-edge5
content-type
image/webp
cache-control
public, max-age=604800
x-hcdn-image-optimizer
f:webp q:85 w:1600
x-hcdn-upstream-rt
0.822
accept-ranges
bytes
alt-svc
h3=":443"; ma=86400
content-length
22140
cd-icon-close.svg
biopharmaapac.com/bundles/taai/app/site/images/
696 B
750 B
Image
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/images/cd-icon-close.svg
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
154.62.105.146 Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
ba3c42c97d16d249855dcfeed7daf64b7a6f56bb45948a5b6409c39bf037da92
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/bundles/taai/app/site/css/style.css
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:48 GMT
content-encoding
br
content-security-policy
upgrade-insecure-requests
alt-svc
h3=":443"; ma=86400
content-length
351
x-hcdn-cache-status
MISS
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
etag
"2b8-658841b5-4ebfd1f75862087e;br"
x-hcdn-request-id
80db4c7dc3bbf532615d1363f35c3b18-srv-edge5
content-type
image/svg+xml
cache-control
public, max-age=604800
x-turbo-charged-by
LiteSpeed
x-hcdn-upstream-rt
0.419
accept-ranges
bytes
platform
hostinger
expires
Fri, 24 May 2024 17:05:48 GMT
fontawesome-webfont.woff
biopharmaapac.com/bundles/taai/app/site/fonts/
82 KB
82 KB
Font
General
Full URL
https://biopharmaapac.com/bundles/taai/app/site/fonts/fontawesome-webfont.woff?v=4.1.0
Requested by
Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/font-awesome.min.css
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
154.62.105.146 Meppel, Netherlands, ASN47583 (AS-HOSTINGER, CY),
Reverse DNS
Software
hcdn /
Resource Hash
66db52b456efe7e29cec11fa09421d03cb09e37ed1b567307ec0444fd605ce31
Security Headers
Name Value
Content-Security-Policy upgrade-insecure-requests

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/bundles/taai/app/site/css/font-awesome.min.css
Origin
https://biopharmaapac.com
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 17:05:48 GMT
content-security-policy
upgrade-insecure-requests
x-hcdn-cache-status
MISS
last-modified
Sun, 24 Dec 2023 14:35:33 GMT
server
hcdn
content-encoding
br
etag
W/"14730-658841b5-d326144e0621bbb4;;;"
vary
accept-encoding
x-hcdn-request-id
beb7f850c6e9be62ceb1db81a194f2f4-srv-edge5
content-type
application/font-woff
x-turbo-charged-by
LiteSpeed
x-hcdn-upstream-rt
0.423
platform
hostinger
alt-svc
h3=":443"; ma=86400
recaptcha__de.js
www.gstatic.com/recaptcha/releases/8k85QBI-qzxmenDv318AZH30/
519 KB
207 KB
Script
General
Full URL
https://www.gstatic.com/recaptcha/releases/8k85QBI-qzxmenDv318AZH30/recaptcha__de.js
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
e92f0b552deffbf207cee5389713056c7c3d27e4b9b9edaf29338d01a83c5962
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/
Origin
https://biopharmaapac.com
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

date
Fri, 17 May 2024 11:46:09 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
19179
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
210834
x-xss-protection
0
last-modified
Mon, 13 May 2024 17:44:43 GMT
server
sffe
cross-origin-opener-policy
same-origin-allow-popups; report-to="recaptcha"
vary
Accept-Encoding
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Sat, 17 May 2025 11:46:09 GMT
widget_iframe.2f70fb173b9000da126c79afe2098f02.html
platform.twitter.com/widgets/ Frame F837
0
0
Document
General
Full URL
https://platform.twitter.com/widgets/widget_iframe.2f70fb173b9000da126c79afe2098f02.html?origin=https%3A%2F%2Fbiopharmaapac.com
Requested by
Host: platform.twitter.com
URL: https://platform.twitter.com/widgets.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2606:2800:234:59:254c:406:2366:268c , United States, ASN15133 (EDGECAST, US),
Reverse DNS
Software
ECS (frb/67BA) /
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9;q=0.9
Referer
https://biopharmaapac.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

Access-Control-Allow-Methods
GET
Access-Control-Allow-Origin
*
Age
4623217
Cache-Control
public, max-age=315360000
Content-Encoding
gzip
Content-Length
105429
Content-Type
text/html; charset=utf-8
Date
Fri, 17 May 2024 17:05:48 GMT
Etag
"81267302efdfb3e4524a22631a8fc99e+gzip"
Last-Modified
Mon, 11 Dec 2023 17:19:49 GMT
P3P
CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
Server
ECS (frb/67BA)
Server-Timing
x-cache;desc= HIT,x-tw-cdn;desc=VZ
Vary
Accept-Encoding
X-Cache
HIT
x-amz-server-side-encryption
AES256
x-tw-cdn
VZ
collect
region1.google-analytics.com/g/
0
255 B
Ping
General
Full URL
https://region1.google-analytics.com/g/collect?v=2&tid=G-2E2BXNMKP4&gtm=45je45f0v877295126za200&_p=1715965548118&gcd=13l3l3l2l1&npa=1&dma_cps=sypham&dma=1&cid=103774456.1715965548&ul=de-de&sr=1600x1200&uaa=x86&uab=64&uafvl=Chromium%3B124.0.6367.207%7CGoogle%2520Chrome%3B124.0.6367.207%7CNot-A.Brand%3B99.0.0.0&uamb=0&uam=&uap=Win32&uapv=10.0.0&uaw=0&frm=0&pscdl=noapi&_s=1&sid=1715965548&sct=1&seg=0&dl=https%3A%2F%2Fbiopharmaapac.com%2Fnews%2F83%2F3647%2Foscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html%3F__s%3Dues769lrvtepkymcf22m%26utm_source%3Ddrip%26utm_medium%3Demail%26utm_campaign%3DCure%2BGenetics%2Band%2BFrametact%2BStrike%2B%252460M%2BDeal%2Bfor%2BFamilial%2BNeurological%2BDisease%2BGene%2BTherapy&dt=Oscotec%2FADEL%20Receives%20FDA%20Clearance%20for%20Alzheimer%27s%20Treatment%20IND%20Application%20(ADEL-Y01)&en=page_view&_fv=1&_nsi=1&_ss=1&_ee=1&tfd=3988
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-2E2BXNMKP4
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4860:4802:32::36 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
Referer
https://biopharmaapac.com/
Accept-Language
de-DE,de;q=0.9;q=0.9
sec-ch-ua-mobile
?0
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua-platform
"Win32"

Response headers

pragma
no-cache
date
Fri, 17 May 2024 17:05:48 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://biopharmaapac.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
anchor
www.google.com/recaptcha/api2/ Frame 3007
0
0
Document
General
Full URL
https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=8k85QBI-qzxmenDv318AZH30&size=normal&cb=yzdymkvhn15o
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/8k85QBI-qzxmenDv318AZH30/recaptcha__de.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
216.58.212.132 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
ams15s21-in-f4.1e100.net
Software
GSE /
Resource Hash
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-avSgyp2U5y2MJ_rJP1N9RQ' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9;q=0.9
Referer
https://biopharmaapac.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-avSgyp2U5y2MJ_rJP1N9RQ' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Fri, 17 May 2024 17:05:48 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
pragma
no-cache
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
anchor
www.google.com/recaptcha/api2/ Frame 580C
0
0
Document
General
Full URL
https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=de&v=8k85QBI-qzxmenDv318AZH30&size=normal&cb=3hclid9yean6
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/8k85QBI-qzxmenDv318AZH30/recaptcha__de.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
216.58.212.132 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
ams15s21-in-f4.1e100.net
Software
GSE /
Resource Hash
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-OVJSM4Ks3u70gvX5WuovKw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9;q=0.9
Referer
https://biopharmaapac.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-OVJSM4Ks3u70gvX5WuovKw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Fri, 17 May 2024 17:05:48 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
pragma
no-cache
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
bframe
www.google.com/recaptcha/api2/ Frame DB18
0
0
Document
General
Full URL
https://www.google.com/recaptcha/api2/bframe?hl=de&v=8k85QBI-qzxmenDv318AZH30&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/8k85QBI-qzxmenDv318AZH30/recaptcha__de.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
216.58.212.132 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
ams15s21-in-f4.1e100.net
Software
GSE /
Resource Hash
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-5A2U36xlAUk3433FpuD5dw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9;q=0.9
Referer
https://biopharmaapac.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-5A2U36xlAUk3433FpuD5dw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Fri, 17 May 2024 17:05:49 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
pragma
no-cache
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block
bframe
www.google.com/recaptcha/api2/ Frame 1FC5
0
0
Document
General
Full URL
https://www.google.com/recaptcha/api2/bframe?hl=de&v=8k85QBI-qzxmenDv318AZH30&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC
Requested by
Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/8k85QBI-qzxmenDv318AZH30/recaptcha__de.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
216.58.212.132 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
ams15s21-in-f4.1e100.net
Software
GSE /
Resource Hash
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-K-7G7KLHbAj-2XqtW73Pcg' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9;q=0.9
Referer
https://biopharmaapac.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/124.0.0.0 Safari/537.36
sec-ch-ua
"Google Chrome";v="124", "Not:A-Brand";v="8", "Chromium";v="124"
sec-ch-ua-mobile
?0
sec-ch-ua-platform
"Win32"

Response headers

alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
no-cache, no-store, max-age=0, must-revalidate
content-encoding
gzip
content-security-policy
script-src 'report-sample' 'nonce-K-7G7KLHbAj-2XqtW73Pcg' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type
text/html; charset=utf-8
cross-origin-embedder-policy
require-corp
cross-origin-resource-policy
cross-origin
date
Fri, 17 May 2024 17:05:49 GMT
expires
Mon, 01 Jan 1990 00:00:00 GMT
pragma
no-cache
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server
GSE
x-content-type-options
nosniff
x-xss-protection
1; mode=block

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
biopharmaapac.com
URL
https://biopharmaapac.com/uploads/articles/biopharma_apac_women_s_day_special-4471.jpg
Domain
biopharmaapac.com
URL
https://biopharmaapac.com/uploads/articles/screenshot_2023_12_13_at_9_44_52_am_1_-4048.jpg

Verdicts & Comments Add Verdict or Comment

41 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 object| 3 object| 4 object| 5 object| 6 object| 7 function| $ function| jQuery function| Popper object| bootstrap function| fncShow function| fncHide function| pagination function| validateEmail function| allNumeric function| saveEnquiry function| getParameterByName string| passwrodLength function| validatePassword function| validateRegistration function| validateLogin function| validateForgotPassword function| isEmailExist function| validateNewsletter object| __twttrll object| twttr object| __twttr function| gtag object| dataLayer object| ___grecaptcha_cfg object| grecaptcha string| __recaptcha_api boolean| __google_recaptcha_client object| google_tag_manager object| google_tag_data function| onYouTubeIframeAPIReady object| gaGlobal object| recaptcha object| closure_lm_985258

6 Cookies

Domain/Path Name / Value
biopharmaapac.com/ Name: PHPSESSID
Value: 4rgehkhl795badvvfdk1h55pq1
.youtube.com/ Name: YSC
Value: F4bSpitn1m0
.youtube.com/ Name: VISITOR_INFO1_LIVE
Value: 4Q6eMSjhtCQ
.youtube.com/ Name: VISITOR_PRIVACY_METADATA
Value: CgJERRIEEgAgFw%3D%3D
.biopharmaapac.com/ Name: _ga_2E2BXNMKP4
Value: GS1.1.1715965548.1.0.1715965548.0.0.0
.biopharmaapac.com/ Name: _ga
Value: GA1.1.103774456.1715965548

1 Console Messages

Source Level URL
Text
recommendation verbose URL: https://biopharmaapac.com/news/83/3647/oscotec-adel-receives-fda-clearance-for-alzheimers-treatment-ind-application-adel-y01.html?__s=ues769lrvtepkymcf22m&utm_source=drip&utm_medium=email&utm_campaign=Cure+Genetics+and+Frametact+Strike+%2460M+Deal+for+Familial+Neurological+Disease+Gene+Therapy
Message:
[DOM] Input elements should have autocomplete attributes (suggested: "current-password"): (More info: https://goo.gl/9p2vKq) %o

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
Content-Security-Policy upgrade-insecure-requests

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

biopharmaapac.com
platform.twitter.com
region1.google-analytics.com
t.dripemail2.com
www.google.com
www.googletagmanager.com
www.gstatic.com
www.youtube.com
biopharmaapac.com
154.62.105.146
2001:4860:4802:32::36
216.58.212.132
2606:2800:234:59:254c:406:2366:268c
2a00:1450:4001:80f::2008
2a00:1450:4001:80f::200e
2a00:1450:4001:812::2003
2a02:4780:39:8769:4c98:84fc:e60:ca1
54.89.218.103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